By Admin at 29 Feb 2016
Glioblastoma is the most common type of brain cancer. It’s often aggressive and has a median survival time of under 15 months on average. Researchers are offering new hope for treatment in this area using an unlikely “weapon” – herpes virus.
By Admin at 24 Feb 2016
There are many mysteries surrounding how and why cancerous tumors form. Although it’s been suggested that tumors are the result of cells sticking together, new research found that the process is not nearly as passive. Instead, tumor cells “actively recruit” other cells in a very determined, purposeful process.
By Admin at 17 Feb 2016
Dietary supplements are incredibly popular among cancer patients. In one study of more than 200 cancer patients receiving treatment, 73 percent had used some form of supplement during the past 30 days.
By Admin at 16 Feb 2016
In research presented at the American Society of Clinical Oncology (ASCO) meeting in San Francisco, California, it was revealed just how common chemotherapy-related nerve damage actually is, even years after treatment has ended.
By Admin at 15 Feb 2016
Researchers from Griffith University's Institute for Glycomics have succeeded in a world first. They’ve used X-ray crystallography to create a 3-D image of a bacterial heparanase, a protein involved in cancer spread.
Current Gateway-funded clinical trials
Clinical trials funded at leading institutions worldwide
Funds one patient for one day at a Gateway-funded clinical trial